Mesothelin targeted cancer immunotherapy
Top Cited Papers
- 31 January 2008
- journal article
- review article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 44 (1), 46-53
- https://doi.org/10.1016/j.ejca.2007.08.028
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Synergistic Antitumor Activity of Taxol and Immunotoxin SS1P in Tumor-Bearing MiceClinical Cancer Research, 2006
- Immunotoxin therapy of cancerNature Reviews Cancer, 2006
- Diffuse Mesothelin Expression Correlates with Prolonged Patient Survival in Ovarian Serous CarcinomaClinical Cancer Research, 2006
- Mesothelin Is Overexpressed in Pancreaticobiliary Adenocarcinomas but Not in Normal Pancreas and Chronic PancreatitisAmerican Journal of Clinical Pathology, 2005
- Identification of Novel Human CTL Epitopes and Their Agonist Epitopes of MesothelinClinical Cancer Research, 2005
- Humoral Immune Response to Mesothelin in Mesothelioma and Ovarian Cancer PatientsClinical Cancer Research, 2005
- Mesothelin-mediated targeting of adenoviral vectors for ovarian cancer gene therapyGene Therapy, 2004
- Mesothelin-specific CD8+ T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer PatientsThe Journal of Experimental Medicine, 2004
- Mechanism and function of signal transduction by the Wnt/β-catenin and Wnt/Ca2+ pathwaysOncogene, 1999
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983